DAYVIGO
DAYVIGO
Approved
DIN Number
02507366
Drug Class
Human
Market Date
Nov 6, 2020
Company
HC
EISAI LIMITED
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02507366
AIG Number0162559001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05CJ02 LEMBOREXANT
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
LEMBOREXANTActive
Strength: 5 MG
Monograph: LEMBOREXANT